National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G ↓	Ingredients	Dosage	Form	Price
J01DH02	MEROZAN	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 10mg/0.2ml	10mg/0.2ml	Injectable solution	1,553,482 L.L
J01DH02	MIRAN	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	819,744 L.L
M03BC51	MUSCEROL 2	G	Paracetamol - 450mg, Orphenadrine (citrate) - 35mg		Tablet, scored	177,899 L.L
A01AB09	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	229,093 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 15mg/0.3ml	15mg/0.3ml	Injectable solution	1,968,729 L.L
M03BC51	MUSCEROL EXTRA	G	Caffeine - 15mg, Paracetamol - 450mg, Orphenadrine citrate - 35mg		Tablet, scored	267,489 L.L
A01AB09	MICOZOLE	G	Miconazole - 20mg/g	20mg/g	Gel	104,820 L.L
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	406,810 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 20mg/0.4ml	20mg/0.4ml	Injectable solution	2,134,022 L.L
M03BC51	MUSCEROL 3	G	Paracetamol - 450mg, Orphenadrine citrate - 35mg, Ibuprofen - 200mg		Tablet, film coated	593,850 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	579,064 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 25mg/0.5ml	25mg/0.5ml	Injectable solution	2,582,865 L.L
B05BC01	MANNITOL	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	613,662 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	374,633 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	613,662 L.L
B05BC01	MANNITOL 20% INJECTION USP	G	Mannitol - 20%	20%	Injectable solution	344,754 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
B05BC01	MANNITOL 20% INJECTION, USP	G	Mannitol - 20g/100ml	20g/100ml	Injectable solution	402,213 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	851,996 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	1,184,140 L.L
S01EB09	MIOVISIN	G	Acetylcholine chloride - 20mg/2ml	20mg/2ml	Injectable powder for solution+solvent	6,449,100 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	329,815 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	494,147 L.L
A02BB01	MISOFAR	G	Misoprostol - 200mcg	200mcg	Tablet	1,546,763 L.L
B05BC01	MANNITOL 10% USP INJECTION	G	Mannitol - 10%	10%	Injectable solution	430,943 L.L
A02BB01	MISOFAR	G	Misoprostol - 25mcg	25mcg	Tablet	1,855,846 L.L
A06AG11	MINILAX	G	Sodium citrate (dihydrate) - 900mg/10ml, Sodium lauryl sulfate - 150mg/10ml, Glycerol - 1200mg/10ml, Sorbic acid - 10mg/10ml, Sorbitol - 9.96mg/10ml		Solution	474,824 L.L
B05BC01	MANNITOL 10% USP INJECTION	G	Mannitol - 10%	10%	Injectable solution	326,367 L.L

...